227 related articles for article (PubMed ID: 15940895)
41. Replacement of in vivo acute oral toxicity studies by in vitro cytotoxicity methods: opportunities, limits and regulatory status.
Ukelis U; Kramer PJ; Olejniczak K; Mueller SO
Regul Toxicol Pharmacol; 2008 Jun; 51(1):108-18. PubMed ID: 18362045
[TBL] [Abstract][Full Text] [Related]
42. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds.
Festag M; Viertel B; Steinberg P; Sehner C
Toxicol In Vitro; 2007 Dec; 21(8):1631-40. PubMed ID: 17719739
[TBL] [Abstract][Full Text] [Related]
43. Validation of the embryonic stem cell test in the international ECVAM validation study on three in vitro embryotoxicity tests.
Genschow E; Spielmann H; Scholz G; Pohl I; Seiler A; Clemann N; Bremer S; Becker K
Altern Lab Anim; 2004 Sep; 32(3):209-44. PubMed ID: 15588166
[TBL] [Abstract][Full Text] [Related]
44. The principles of validation and the ECVAM validation process.
Worth AP; Balls M
Altern Lab Anim; 2002 Dec; 30 Suppl 2():15-21. PubMed ID: 12513647
[TBL] [Abstract][Full Text] [Related]
45. The Use of In Vitro Systems for Evaluating Immunotoxicity: The Report and Recommendations of an ECVAM Workshop.
Gennari A; Ban M; Braun A; Casati S; Corsini E; Dastych J; Descotes J; Hartung T; Hooghe-Peters R; House R; Pallardy M; Pieters R; Reid L; Tryphonas H; Tschirhart E; Tuschl H; Vandebriel R; Gribaldo L
J Immunotoxicol; 2005 Apr; 2(2):61-83. PubMed ID: 18958661
[TBL] [Abstract][Full Text] [Related]
46. AGAATI/ECVAM Workshop on the Validation of Alternative Methods for the Potency Testing of Vaccines.
Halder M; Hendriksen CF; Spieser JM
ALTEX; 1998; 15(5):5. PubMed ID: 11178524
[TBL] [Abstract][Full Text] [Related]
47. Animal testing: more than a cosmetic change.
Abbott A
Nature; 2005 Nov; 438(7065):144-6. PubMed ID: 16281001
[No Abstract] [Full Text] [Related]
48. Implementation of three Rs alternatives in regulatory testing: possibilities and obstacles--the view of the validator.
Halder M; Balls M
Dev Biol (Basel); 2002; 111():199-206. PubMed ID: 12678242
[TBL] [Abstract][Full Text] [Related]
49. Directions in QSAR modeling for regulatory uses in OECD member countries, EU and in Russia.
Fjodorova N; Novich M; Vrachko M; Smirnov V; Kharchevnikova N; Zholdakova Z; Novikov S; Skvortsova N; Filimonov D; Poroikov V; Benfenati E
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(2):201-36. PubMed ID: 18569330
[TBL] [Abstract][Full Text] [Related]
50. Validation of the Chick Embryotoxicity Screening Test (CHEST). A comparative study.
Jelínek R; Marhan O
Funct Dev Morphol; 1994; 4(4):317-23. PubMed ID: 7612953
[TBL] [Abstract][Full Text] [Related]
51. In vitro skin irritation testing on reconstituted human epidermis: reproducibility for 50 chemicals tested with two protocols.
Tornier C; Rosdy M; Maibach HI
Toxicol In Vitro; 2006 Jun; 20(4):401-16. PubMed ID: 16229985
[TBL] [Abstract][Full Text] [Related]
52. The role of ICCVAM in evaluating new and alternative test methods.
Stokes WS; Hill RN
Lab Anim (NY); 2002; 31(7):26-32. PubMed ID: 12200591
[No Abstract] [Full Text] [Related]
53. Report of the EPAA-ECVAM workshop on the validation of Integrated Testing Strategies (ITS).
Kinsner-Ovaskainen A; Maxwell G; Kreysa J; Barroso J; Adriaens E; Alépée N; Berg N; Bremer S; Coecke S; Comenges JZ; Corvi R; Casati S; Dal Negro G; Marrec-Fairley M; Griesinger C; Halder M; Heisler E; Hirmann D; Kleensang A; Kopp-Schneider A; Lapenna S; Munn S; Prieto P; Schechtman L; Schultz T; Vidal JM; Worth A; Zuang V
Altern Lab Anim; 2012 Jul; 40(3):175-81. PubMed ID: 22943518
[TBL] [Abstract][Full Text] [Related]
54. [Irritant contact dermatitis. Part II. Evaluation evaluation of skin irritation potential of chemicals].
Chomiczewska D; Kieć-Swierczyńska M; Krecisz B
Med Pr; 2009; 60(3):209-14. PubMed ID: 19746889
[TBL] [Abstract][Full Text] [Related]
55. Response to "The microEST in vitro test for embryotoxicity - a case of mistaken identity?" by Robert Combes.
Schwengberg S; Bohlen H; Fronhoff B
Toxicol In Vitro; 2009 Mar; 23(2):362-3. PubMed ID: 19111605
[No Abstract] [Full Text] [Related]
56. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
[TBL] [Abstract][Full Text] [Related]
57. Alternative test methods in inhalation toxicology: challenges and opportunities.
Costa DL
Exp Toxicol Pathol; 2008 Jun; 60(2-3):105-9. PubMed ID: 18486462
[TBL] [Abstract][Full Text] [Related]
58. Validation of tests methods in the quality control of biologicals.
Hendriksen CF
Dev Biol Stand; 1999; 101():217-21. PubMed ID: 10566796
[TBL] [Abstract][Full Text] [Related]
59. Validation of the rat limb bud micromass test in the international ECVAM validation study on three in vitro embryotoxicity tests.
Spielmann H; Genschow E; Brown NA; Piersma AH; Verhoef A; Spanjersberg MQ; Huuskonen H; Paillard F; Seiler A
Altern Lab Anim; 2004 Sep; 32(3):245-74. PubMed ID: 15588167
[TBL] [Abstract][Full Text] [Related]
60. Validation of Alternative In Vitro Methods to Animal Testing: Concepts, Challenges, Processes and Tools.
Griesinger C; Desprez B; Coecke S; Casey W; Zuang V
Adv Exp Med Biol; 2016; 856():65-132. PubMed ID: 27671720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
